Response of diabetic papillopathy to intravitreal bevacizumab
MEAJO-Middle East African Journal of Ophthalmology. 2011; 18 (3): 243-245
in English
| IMEMR
| ID: emr-130064
ABSTRACT
Diabetic papillopathy is an uncommon hyperemic optic disc swelling that occurs in patients with long-standing diabetes, is typically self-resolving with minimal effect on vision, and is likely ischemic in origin. The purpose of the current report is to document the response of diabetic papillopathy to intravitreal injection of bevacizumab [Avastin, Genentech Inc, San Francisco, California, USA], a humanized monoclonal antibody to vascular endothelial growth factor
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Vitreous Body
/
Treatment Outcome
/
Angiogenesis Inhibitors
/
Vascular Endothelial Growth Factor A
/
Diabetic Retinopathy
/
Injections
/
Antibodies, Monoclonal
Type of study:
Case report
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Middle East Afr. J. Ophthalmol.
Year:
2011
Similar
MEDLINE
...
LILACS
LIS